Home Newsfeeds Credit Suisse Maintains Outperform on Avidity Biosciences, Raises Price Target to $35

Credit Suisse Maintains Outperform on Avidity Biosciences, Raises Price Target to $35

Credit Suisse analyst Judah Frommer maintains Avidity Biosciences (NASDAQ:RNA) with a Outperform and raises the price target from $33 to $35.

byBenzinga Newsdesk

December 15, 2022

1 minute read

Credit Suisse analyst Judah Frommer maintains Avidity Biosciences (NASDAQ:RNA) with a Outperform and raises the price target from $33 to $35.

Nvidia Is Poised To Join The $1 Trillion Club, Thanks To The AI Revolution

By Bibhu Pattnaik

May 27, 2:18 PM

NVIDIA Corporation (NASDAQ: NVDA) is all set to become the fifth publicly traded company to be worth $1 trillion, joining Apple Inc (NASDAQ: AAPL), Microsoft Corp (NASDAQ:

AAPL

Raymond James Maintains Strong Buy on Polaris, Raises Price Target to $130

By Benzinga Newsdesk

February 1, 8:17 AM

Raymond James analyst Joseph Altobello maintains Polaris (NYSE:PII) with a Strong Buy and raises the price target from $123 to $130.

PII

Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales

By Avi Kapoor

January 5, 3:30 PM

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 50 points on Friday. The Dow traded up 0.13% to 37,490.36 while the NASDAQ rose 0.25% to 14,546.77. The S&P 500 also rose, gaining, 0.26% to 4,701.05.

AGL

Spotify’s Price Increases and Improved Metrics Signal Growth Potential, Analyst Upgrades Stock

By Anusuya Lahiri

July 26, 1:38 PM

Deutsche Bank analyst Benjamin Black upgraded Spotify Technology SA (NYSE: SPOT) from Hold to Buy

SPOT

Credit Suisse Maintains Outperform on Avidity Biosciences, Raises Price Target to $35

Related Posts

Nvidia Is Poised To Join The $1 Trillion Club, Thanks To The AI Revolution

Raymond James Maintains Strong Buy on Polaris, Raises Price Target to $130

Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales

Spotify’s Price Increases and Improved Metrics Signal Growth Potential, Analyst Upgrades Stock